Liposome Encapsulated Doxorubicin Citrate (Ledc) as an Alternative Therapeutic Option for Patients with Recurrent Ovarian Cancer Suffering from Doxorubicin-Related Cutaneous Toxicity

Roberto Angioli¹, Michela Angelucci^1*, Francesco Plotti¹, Corrado Terranova¹, Roberto Montera¹, Patrizio Damiani¹, Ester Valentina Cafa¹, Pierluigi Benedetti Panici² and Angiolo Gadducci³

¹Department of Obstetrics & Gynaecology, Campus Bio Medico University of Rome, Rome, Italy

²Department of Obstetrics & Gynaecology, “Sapienza” University of Rome, Rome, Italy

³Department of Obstetrics & Gynaecology, University of Pisa, Rome, Italy

^*Corresponding Author: Michela Angelucci, Department of Obstetrics & Gynaecology, University of Rome “Campus Bio-Medico”, Via Álvaro Del Portillo, 200-00128 Rome, Italy Email: